Tag:
Servier
Latest Headlines
Latest Headlines
Europe wants more restrictions on Servier's Protelos
Citing heart risks, an EMA committee has recommended further restrictions for Protelos, an osteoporosis drug made by Servier, the company at the center of a scandal in France for off-label use of its Mediator diabetes drug, which also was tied to heart risks.
French drug exec charged with manslaughter over drug safety
For 10 years after the U.S. and other countries had withdrawn the French diabetes drug Mediator from the market because of serious health concerns, authorities in France permitted Servier to continue selling it there. Now that it is a national scandal, authorities have hauled founder Louis Servier into court twice in less than 10 months, this time on charges of manslaughter.
Servier served with manslaughter charge
For 10 years after the U.S. and other countries had withdrawn the French diabetes drug Mediator from the market because of serious health concerns, authorities in France permitted Servier to continue selling it there. Now that it is a national scandal, authorities have hauled founder Louis Servier into court twice in less than 10 months, this time on charges of manslaughter.
Xoma hunts for marketing partner as blood pressure med clears PhIII
Xoma says it hit its primary endpoint in a late-stage test of a blood pressure combo including Servier's perindopril, setting the stage for an NDA as the biotech goes hunting for a partner to market the therapy in the U.S.
MacroGenics banks $20M in potential $1.1B cancer-drugs deal with Servier
MacroGenics has landed another pharma deal. This time, the biotech has sealed a second pact with French drugmaker Servier, which has tapped MacroGenics' Dual-Affinity Re-Targeting (DART) platform in an option-based deal focused on bi-specific antibodies against three mystery cancer-immune targets, the U.S. biotech announced this morning.
European antitrust squad to charge Lundbeck, Servier
European antitrust officials have zeroed in on Lundbeck and Servier. The two drugmakers are about to face charges that their attempts to fight off cheap generics violated competition laws.
EU prepares tougher drug recall standards
In another response to questionable oversight by drug regulators in Europe, the EU is looking at more stringent regulations for requiring drug manufacturers to recall products.
Servier, founder face trial on Mediator charges
The French health ministry says Mediator caused at least 500 deaths.
Roche headlines autism alliance
A European research effort led by Roche ( $RHHBY ) and others to tackle autism spectrum disorders nailed down $38.7 million in financing for what will be a massive, 5-year project seeking to come up with new diagnostic and treatment options.
Mediator probe enlightens French public on drug risks
As public trust in drug regulation crumbles in France over alleged misdeeds in the marketing of Servier 's diabetes pill Mediator , politicians and health officials are scrambling to restore faith in a
